K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancer.
Eng
Cathy
C
GI Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000556:secondary*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000187:drug effects*; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D007155:Immunologic Factors; D009154:Mutation; D009362:Neoplasm Metastasis / Q000188:drug therapy; D000077544:Panitumumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000077544:Panitumumab; C512478:EGFR protein, human; D066246:ErbB Receptors; D000068818:Cetuximab